GNLX
Genelux Corp

496
Mkt Cap
$107.53M
Volume
504,717.00
52W High
$8.54
52W Low
$1.99
PE Ratio
-2.77
GNLX Fundamentals
Price
$2.40
Prev Close
$2.54
Open
$2.40
50D MA
$2.68
Beta
1.37
Avg. Volume
187,744.05
EPS (Annual)
-$0.8647
P/B
7.84
Rev/Employee
$307.69
$149.18
Loading...
Loading...
News
all
press releases
Genelux (NASDAQ:GNLX) Upgraded by Wall Street Zen to "Hold" Rating
Wall Street Zen upgraded Genelux from a "sell" rating to a "hold" rating in a research note on Saturday...
MarketBeat·11h ago
News Placeholder
More News
News Placeholder
Genelux (NASDAQ:GNLX) Price Target Cut to $20.00 by Analysts at Benchmark
Benchmark cut their price target on Genelux from $23.00 to $20.00 and set a "speculative buy" rating on the stock in a research report on Friday...
MarketBeat·1d ago
News Placeholder
Genelux (NASDAQ:GNLX) Director Sells $29,000.00 in Stock
Genelux Corporation (NASDAQ:GNLX - Get Free Report) Director John Thomas sold 10,000 shares of Genelux stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average...
MarketBeat·17d ago
News Placeholder
Insider Selling: Genelux (NASDAQ:GNLX) Director Sells 10,000 Shares of Stock
Genelux Corporation (NASDAQ:GNLX - Get Free Report) Director John Thomas sold 10,000 shares of the company's stock in a transaction on Monday, March 2nd. The stock was sold at an average price of...
MarketBeat·18d ago
News Placeholder
Genelux (NASDAQ:GNLX) Shares Down 2.7% - Should You Sell?
Genelux (NASDAQ:GNLX) Stock Price Down 2.7% - What's Next...
MarketBeat·22d ago
News Placeholder
Genelux (NASDAQ:GNLX) Trading Down 5.1% - Time to Sell?
Genelux (NASDAQ:GNLX) Trading Down 5.1% - What's Next...
MarketBeat·1mo ago
News Placeholder
Genelux (NASDAQ:GNLX) Stock Rating Lowered by Wall Street Zen
Wall Street Zen downgraded shares of Genelux from a "hold" rating to a "sell" rating in a report on Sunday...
MarketBeat·2mo ago
News Placeholder
Genelux (NASDAQ:GNLX) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen raised shares of Genelux from a "sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat·3mo ago
News Placeholder
Genelux Corp Appoints Jason Litten CMO
(RTTNews) - Genelux Corp. (GNLX), a clinical-stage immuno-oncology company, Friday announced that it has appointed Jason Litten as Chief Medical Officer, effective January 2...
Nasdaq News: Markets·3mo ago
News Placeholder
Flputnam Investment Management Co. Raises Holdings in Genelux Corporation $GNLX
Flputnam Investment Management Co. lifted its stake in Genelux Corporation (NASDAQ:GNLX - Free Report) by 708.1% in the 3rd quarter, according to its most recent filing with the Securities & Exchange...
MarketBeat·3mo ago
<
1
2
...
>

Latest GNLX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.